UK Dividend Aristocrats 2026: 8 LSE Stocks With 20+ Years of Rising Payouts
Dividend growth investing and value investing are complementary disciplines. We've screened the LSE for companies raising dividends through every major crisis since 2000.
Dividend growth investing is value investing in disguise. A company that has raised its dividend every year for 20+ years through recessions, rate cycles, and market crashes is, almost by definition, generating durable excess cash flow. When that company also trades at a discount to intrinsic value, you have the rare combination of income, safety, and capital appreciation.
What Qualifies as a Dividend Aristocrat on the LSE?
The US has an official S&P 500 Dividend Aristocrats index requiring 25 consecutive years of increases. The UK has no equivalent index, but we've applied the same screen to LSE constituents: minimum 20 consecutive years of dividend increases or no cuts through the 2020 COVID period (which we treat as a special exclusion given the government-mandated banking sector dividend freezes).
= bar_chart(['ULVR','RKT','DGE','AZN','VOD'],[38,31,27,22,18],'#00DC82',400,120) ?>The Eight Names
Unilever (ULVR.L) — 38 consecutive years. Consumer goods with global pricing power. Currently yielding ~3.5% with a payout ratio of approximately 68%, suggesting coverage is sustainable.
Reckitt Benckiser (RKT.L) — 31 years. Health, hygiene and nutrition brands including Dettol and Nurofen. Higher debt than Unilever but pricing power in defensive categories.
Diageo (DGE.L) — 27 years. Premium spirits with the strongest brand portfolio in the sector. Free cash flow conversion is exceptional — roughly 85-90% of operating profit.
AstraZeneca (AZN.L) — 22 years. Pharmaceuticals with a strong oncology pipeline. Dividend yield is relatively low at ~2% but the growth rate (8% annually) is superior.
National Grid (NG.L) — 20 years. Regulated utility with essentially guaranteed revenue. Dividend yield ~5.5% but growth is modest. Good for income-focused portfolios.
Haleon (HLN.L) — Spun out from GSK in 2022, inheriting a strong track record. Consumer health brands including Sensodyne and Voltaren. Still early in its independent dividend history but strong cash generation.
Compass Group (CPG.L) — Contract catering with recurring revenue from long-term institutional contracts. Dividend was cut in COVID (excluded from the strict 25-year criterion) but has since been restored and exceeded pre-pandemic levels.
Experian (EXPN.L) — Data analytics and credit reporting. Structural growth in financial services data. Dividend growth averaging 7-8% annually over 15 years.
Building a Dividend Aristocrats Portfolio
Equal-weighting across all eight provides a yield of approximately 3.5-4.5% depending on current prices. The key is holding through corrections — companies that have raised dividends for 20+ years tend to keep doing so even when their stock price falls. This makes them particularly suitable for ISA and SIPP portfolios where income is tax-sheltered.
Yield data as of Q1 2026. Past dividend payments do not guarantee future payments. This article is for educational purposes only and does not constitute investment advice.
Disclaimer: Not financial advice. DipBuster is an information platform. Always do your own research before investing.